Additionally, Loganin suppresses the canonical NLRP3/Caspase-1/Gasdermin D pathway, reducing fasting blood glucose, blood urea nitrogen, and serum creatinine levels in DKD mice while alleviating renal pathological changes (172). Here, CASP1 is linked to diabetic kidney disease.